Hence, suppression of HDAC10 autophagy may be a novel strategy to sustain the cytotoxicity of cancer chemotherapy, especially for the treatment of advanced-stage neuroblastoma [16]. The gene discussed is HDAC10; the disease is neuroblastoma.